In this issue: Harnessing immunity against difficult targets, through the CD40-CD40L pathway

International Reviews of Immunology

Volumn 31, Issue 4, 2012, Pages 243-245

  Kornbluth, Richard S ^a   Bot, Adrian ^b  

^a BIOTHERAPEUTICS INC   (United States)

^b Kite Pharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; IMMUNITY; INNATE IMMUNITY; PRIORITY JOURNAL; TUMOR IMMUNOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; INFECTION; MOLECULAR TARGETED THERAPY; NEOPLASMS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84863905290     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.702511     Document Type: Article

References (0)